A needle-free way to detect fatty liver in kids? a new study puts a multi-test panel to the test.

NCT ID NCT07731360

First seen Jul 28, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests whether a combination of blood markers, ultrasound, and genetic information can accurately diagnose metabolic dysfunction-associated steatotic liver disease (MASLD) in children aged 8 to 18 with obesity. Each child provides a blood sample, undergoes a liver ultrasound, and gives a cheek swab for genetic testing. The goal is to see if this non-invasive panel can reliably identify MASLD without a liver biopsy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple, needle-free way to diagnose fatty liver disease in children with obesity, avoiding the need for a liver biopsy.
What could go wrong
This is a small, early pilot study. The diagnostic panel may not prove accurate enough to replace current methods, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kayseri City Hospital

    Kayseri, 38080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.